INTS

2.4551.80%
RL

Riccardo Lencioni

Member of Scientific Advisory Board

Prof. Riccardo Lencioni, M.D., Ph.D., FSIR, EBIR, is the Founder of the International Liver Cancer Association. Prof. Lencioni serves as an Advisor of Biocompatibles International Ltd. He serves as a member of the Governing Board at International Liver Cancer Association. He serves as Member of Scientific Advisory Board of Perfint Healthcare Pvt. Ltd. He has been a Member of Scientific Advisory Board at Intensity Therapeutics, Inc. since October 22, 2015. Prof. Lencioni served as a Member of Medical Advisory Board at Delcath Systems Inc. since December 2009. He is Member of Liver Cancer Advisory Board at SillaJen Biotherapeutics, Inc. He is Chairman of the Membership Committee of the Cardiovascular and Interventional Radiological Society of Europe and Chairman of the Programme Committee of the European Conference on Interventional Oncology. He is also a member of the Steering Committee of the World Conference on Interventional Oncology. Prof. Lencioni has edited seven books and has authored 135 articles in peer-reviewed international journals and 40 book chapters in textbooks of Radiology, Gastroenterology and Surgery. He has been an invited or honorary lecturer for more than 400 international meetings and conferences. Having completed two fellowships in Interventional Radiology, he has served as a faculty member in various residency programs, including Radiology, Surgery and Gastroenterology. Prof. Lencioni serves as an Associate Professor of Radiology at the University of Pisa in Italy and the Director of the Division of Diagnostic Imaging and Intervention at Pisa University Hospital. He has been a Visiting Professor at 20 different European, American and Asian universities. Prof. Lencioni earned his medical degree with honors from the University of Pisa, where he is board certified in Radiology and Gastroenterology.

Positions